$CVEO

Civeo Corp (CVEO): Results of Operations and Financial Condition

Civeo Corp (CVEO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cveo-06302026xrelease.htm EX-99.1 Document Civeo Reports Second Quarter 2026 Results Highlights: • Reported revenues of $180.0 million, net loss of $2.5 million and Adjusted EBITDA of $23.8 million; • Consolidated revenues increased 11%, driven by integrated services gr

Original reporting
Published Jul 30, 2026, 11:54 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 12:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CVEO
Neutral
medium confidence
Mentioned
$CVEO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CVEONeutralMed
01

Why it matters

The filing provides a full earnings snapshot (revenues, net loss, operating cash flow, Adjusted EBITDA) and a new financing event (convertible notes) with explicit terms plus an ongoing repurchase authorization execution.

02

Market read

Traders can update valuation and balance-sheet risk using the disclosed convertible terms, repurchase progress, and segment-level operating drivers.

03

What to watch

The conversion price premium (~20% to July 1 close) and stated non-dilution framing depend on future share performance; traders should also monitor liquidity ($82.2M) versus net debt (2.1x leverage) for downside risk.

Relevance 7/10Novelty 8/10Timing: filed pre-market today, with July 7 close of the $115M convertible and concurrent buyback disclosed

Background

Civeo filed an SEC 8-K with Q2 2026 results and disclosed subsequent capital allocation actions tied to North American infrastructure opportunities.

Company-level read

Ticker impact

$CVEONeutralMedium confidence
Context

Civeo reported Q2 results and, after quarter-end, issued $115M 4.50% convertible notes plus a concurrent $22.3M share repurchase.

Expected impact

Near-term volatility likely around the capital raise details and buyback pace, with direction dependent on how investors weigh fixed-rate funding versus dilution risk.

Evidence & confidence

The filing discloses Q2 revenue, cash flow, and Adjusted EBITDA plus specific financing terms (coupon, maturity, conversion price premium) and repurchase size, giving traders concrete inputs for valuation and balance-sheet risk.

Market effects

Convertible issuance and buyback may signal improved access to fixed-rate capital for lodging and workforce housing operators tied to energy and infrastructure demand.

Canada and Australia segment drivers (occupancy, integrated services, FX) highlight sensitivity to local demand cycles and currency moves.

Limited direct global spillover, but LNG and energy-infrastructure exposure can affect sentiment toward related industrial services demand.

Counterpoint

Despite revenue growth, Adjusted EBITDA softness from Canada contract start-up costs and Australia occupancy headwinds could limit multiple expansion even after the financing.

Key entities

  • Civeo Corporation

    Reported Q2 2026 results and disclosed $115M convertible notes due 2031 and concurrent share repurchases.

  • 4.50% convertible senior notes due 2031

    $115M aggregate principal issued July 2026 with fixed coupon and an initial conversion price around $40.51 per share.

Related articles

$CVEOMedAI 8/10

Civeo (CVEO) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Bradley Dodson Chief Financial Officer and Treasurer - Collin Gerry Vice President, Corporate Development - Regan Nielsen TAKEAWAYS Total Revenue -- $180 million, representing an 11% increase from $162.7 million in the prior year period. Net Loss -- $2.5 million, compared to a net loss of $3.3 million in the second quarter of 2025.

$CVEOMedAI 8/10

Civeo Reports Second Quarter 2026 Results

Civeo (NYSE:CVEO) reported Q2 2026 revenues of $180.0M, net loss of $2.5M, and Adjusted EBITDA of $23.8M. Revenues rose 11% year over year, helped by integrated services and higher Canada occupancy. After quarter-end, it issued $115.0M 4.50% convertible notes due 2031 and repurchased 660,297 shares for about $22.3M.

$CVEOMedAI 8/10

Civeo Corporation Prices $100.0 Million Convertible Senior Notes Offering

Civeo (NYSE: CVEO) priced a $100.0 million offering of 4.50% convertible senior notes due 2031 in a Rule 144A private placement, settling July 7, 2026. Notes convert at 24.6840 shares per $1,000 (initial conversion price ~$40.51), ~20% above $33.76. Net proceeds ~$96.2 million; up to $110.8 million with option. Proceeds: $22.3 million to repurchase 660,297 shares and remainder to repay debt.

$CVEOMedAI 8/10

Civeo Awarded Six-Year Western Canada Contract Renewal

Civeo Corporation (NYSE: CVEO) said a Western Canada joint venture received a six-year contract renewal to provide workforce accommodations and hospitality services. The agreement runs through June 30, 2032, replacing arrangements due to expire in 2027, and covers services across Civeo’s Western Canada lodge network.

$INBKMedAI 8/10

First Internet Bancorp (INBK) Q2 2026 Earnings Call Transcript

First Internet Bancorp (INBK) reported Q2 2026 revenue of $41.1 million, up 23%, and non-GAAP diluted EPS of $0.27 versus $0.02 a year earlier. Net interest margin (FTE) rose to 2.47%. Credit costs eased, but net charge-offs were $16.9 million. Full-year 2026 EPS guidance is $2.35 to $2.45.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.